Home Finance Novartis Rethinks Sales Strategy for New Cholesterol Drug Launch

Novartis Rethinks Sales Strategy for New Cholesterol Drug Launch


Novartis Rethinks Sales Technique for New Cholesterol Drug Introduce

< img srcset=" https://images.wsj.net/im-438000?width=540&size=1.5 540w, https://images.wsj.net/im-438000?width=620&size=1.5 620w, https://images.wsj.net/im-438000?width=639&size=1.5 639w, https://images.wsj.net/im-438000?width=860&size=1.5 860w, https://images.wsj.net/im-438000?width=860&size=1.5&pixel_ratio=1.5 1290w, https://images.wsj.net/im-438000?width=860&size=1.5&pixel_ratio=2 1720w, https://images.wsj.net/im-438000?width=860&size=1.5&pixel_ratio=3 2580w "src=" https://images.wsj.net/im-438000?width=860&height=573" layout= "responsive" placeholder height=" 573" width=" 860 "alt > The Cambridge, Mass., campus of Novartis, which expects its brand-new cholesterol drug to become one of its most significant sellers.

Picture: brian snyder/Reuters

Published at Sun, 21 Nov 2021 16:00:00 +0000


Previous articleWaukesha Christmas Parade Live Updates: At Least 5 Dead, 40 Injured After SUV Drives Into Crowd
Next articleKristen Stewart Says She Doesn’t “Give a Sh*t” If She Gets Nominated for an Oscar for ‘Spencer’